New Delhi/ Moscow, November 29, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is 80% effective against coronavirus infection from 6th to 8th months after administering the second dose.
Efficacy of Sputnik V on 6-8 months is much higher than officially published efficacy of mRNA vaccines. Sputnik team believes that adenoviral vaccines provide for longer efficacy than mRNA vaccines due to longer antibody and T-cell response.
The data is based on the number of COVID infections in San Marino in November 2021. Efficacy was calculated based on data obtained from over 18,600 individuals fully vaccinated with Sputnik V not less than 5 months before November.
The hospitalization rate with COVID infection following vaccination with Sputnik V in San Marino was only 0.75 per 1,000 people during the entire mass vaccination in the country from February to November 2021. This rate is more than 2 times lower than that of any other vaccine used in the country.
Over 70% of the adult population of San Marino have been vaccinated with Sputnik V.
An article published in EClinicalMedicine (an open access clinical journal published by The Lancet, one of the world's most respected medical journals) in July demonstrated that the Russian vaccine has a high safety profile in San Marino. In particular, Sputnik V shows high tolerability profile in ≥60 age group with nearly all reported adverse events following immunization being mild or moderate and lasting less than 2 days.
Sputnik V pioneered the heterogeneous boosting approach (a “vaccine cocktail” using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component). This approach was proven to be successful in creating a longer and more durable immunity against coronavirus. Sputnik team offered its booster shot (one-shot Sputnik Light vaccine) to other vaccines to lengthen and strengthen their immune response and took the lead in initiating partnerships around the world to conduct joint studies on the combination of Sputnik Light with vaccines of other producers.
*This Press Release is published by team VOH*
Mindray Innovation Empowers Asian Games Host City Hangzhou and Beyond
Apollo Telehealth: Revolutionizing Healthcare Access Through Innovation
Dr Arvind Sharma appointed as New Executive Committee (EC) member Indian Academy
SRV Hospitals Expands its Footprint with the Launch of its Fifth Hospital in Nas
India's leading Gastroenterologist Dr Amit Maydeo joins Sir HN Reliance Foundati
Sir H. N. Reliance Foundation Hospital Takes Bold Strides to Combat Sepsis; laun
IHH Healthcare increases majority stake in India’s Gleneagles Global Hospitals
CK Birla Hospital Signs MOU with Intuitive India for launching Fourth Gen da Vin
Amrita Hospital, Faridabad, Celebrates First Anniversary of its Founding
Compassion knows no borders: At MSF's Health and Humanity Summit, a new communit
Rare Diseases Policy Summit: A DAY OF RARE INSIGHTS
ZEISS SMILE: Pioneering Vision Correction Technology Experiencing Rapid Adoption
$500K PRE-SERIES A FUNDING FOR MONITRA HEALTHCARE
Revolutionary Breakthrough in Cardiac Healthcare: AI-Powered Screening for Left
Tata 1mg Labs Commits Free Anemia Screenings for 10,000 Women and ChildrenView All